The cardiovascular effects of monoamine oxidase inhibitors. 1963

M J DAVEY, and J B FARMER, and H REINERT

UI MeSH Term Description Entries
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D009526 Nialamide An MAO inhibitor that is used as an antidepressive agent.
D002319 Cardiovascular System The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body. Circulatory System,Cardiovascular Systems,Circulatory Systems
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M J DAVEY, and J B FARMER, and H REINERT
March 1966, Pharmacological reviews,
M J DAVEY, and J B FARMER, and H REINERT
January 1985, Clinical and experimental pharmacology & physiology,
M J DAVEY, and J B FARMER, and H REINERT
January 1966, Comptes rendus des seances de la Societe de biologie et de ses filiales,
M J DAVEY, and J B FARMER, and H REINERT
October 1960, Biochemical pharmacology,
M J DAVEY, and J B FARMER, and H REINERT
May 1986, The Journal of clinical psychiatry,
M J DAVEY, and J B FARMER, and H REINERT
January 1983, Modern problems of pharmacopsychiatry,
M J DAVEY, and J B FARMER, and H REINERT
December 1963, Lancet (London, England),
M J DAVEY, and J B FARMER, and H REINERT
August 1964, Lancet (London, England),
M J DAVEY, and J B FARMER, and H REINERT
July 1964, Lancet (London, England),
M J DAVEY, and J B FARMER, and H REINERT
September 1964, Lancet (London, England),
Copied contents to your clipboard!